Welcome to LookChem.com Sign In|Join Free
  • or
N-(2,6-dichlorophenyl)-4-methyl-2-(methylthio)-5-Pyrimidinecarboxamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1452230-52-2

Post Buying Request

1452230-52-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1452230-52-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1452230-52-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,5,2,2,3 and 0 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1452230-52:
(9*1)+(8*4)+(7*5)+(6*2)+(5*2)+(4*3)+(3*0)+(2*5)+(1*2)=122
122 % 10 = 2
So 1452230-52-2 is a valid CAS Registry Number.

1452230-52-2Downstream Products

1452230-52-2Relevant academic research and scientific papers

Investigation of biaryl heterocycles as inhibitors of Wee1 kinase

Mastracchio, Anthony,Lai, Chunqiu,Torrent, Maricel,Bromberg, Kenneth,Buchanan, Fritz G.,Ferguson, Debra,Bontcheva, Velitchka,Johnson, Eric F.,Lasko, Loren,Maag, David,Soni, Nirupama,Shoemaker, Alexander R.,Penning, Thomas D.

supporting information, p. 1481 - 1486 (2019/04/25)

In continuation of our previous research towards the discovery of potent, selective and drug-like Wee1 inhibitors, 2 novel series of biaryl heterocycles were designed, synthesized and evaluated. The new biaryl cores were designed to enable structure?activ

2-AMINOPYRIDO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND THEIR USE AS WEE-1 INHIBITORS

-

Page/Page column 51, (2014/10/29)

The present invention relates to compounds of formula (I) that are useful as inhibitors of the activity of Wee-1 kinase. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds i

PYRIDOPYRIMIDINONE INHIBITORS OF KINASES

-

Paragraph 0489, (2013/09/12)

The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R1, R2, R3, R4, and B are defined in the description. The present invention relates also to compositions cont

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1452230-52-2